Aspiration Needle and Biopsy Needle Market 2025 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2030

Page: 215 | Report Code: LS250115 | Research Suite: Report (PDF) & Market Data (Excel)

NOTE: Due to exhaustive nature of content, full ToC can't be uploaded. Please request Sample Pages to receive full table of content. 

The global market value of Aspiration Needle and Biopsy Needle Market was valued at USD 1.1 billion in 2023, and a CAGR of 7.3% is expected during the forecast period. Rising prevalence of cancer and increasing demand for minimally invasive procedures are driving growth in the market significantly. Rising prevalence of cancer is the main cause behind the growth in the market. The risk of infection associated with the use of aspiration and biopsy needles is driving growth in the market.

Rising incidence of breast, lung, and prostate cancers has increased the demand for biopsy procedures to confirm diagnosis. The growing burden of infectious diseases and chronic conditions requiring diagnostic aspirations is further propelling growth in the market. The development of advanced biopsy and aspiration needles, such as fine-needle aspiration and core needle biopsy devices, ensures higher accuracy and less invasiveness. The introduction of image-guided procedures enhances precision and patient safety.


Growth Drivers

Public health initiatives promoting regular screenings for cancers and other conditions are boosting demand for aspiration and biopsy procedures. Increased access to healthcare services, especially in developing countries, contributes to early diagnosis. The elderly population is at higher risk of cancers and other chronic illnesses, driving the need for diagnostic tools, like aspiration and biopsy.

Increased investment in healthcare infrastructure, particularly in emerging markets, expands access to diagnostic services. Favorable reimbursement policies in many countries encourage patients to undergo necessary diagnostic procedures. Growing preference for minimally invasive procedures and rising awareness among the people about early diagnosis and treatment are driving growth in the market. Use of aspiration, and biopsy needles in liquid biopsies, cytology, and tissue sampling for molecular diagnostics is expanding.

Increasing adoption of biopsy procedures in veterinary care adds to market growth. Initiatives supporting cancer research and diagnostics stimulate the development and adoption of new biopsy techniques. Geriatric people in all over the world are more cancer prone, and they are driving the need for diagnostic tools like aspiration and biopsy needles. Increased access to healthcare services, especially in developing countries, contributes to early diagnoses. Increasing growth in image-guided procedures are driving the market towards success.

Segmentation

By Product Type

·         Biopsy Needles

·         Aspiration Needles

By Application

·         Lung Cancer

·         Breast Cancer

·         Tumor/ Cancer Applicants

·         Colorectal Cancer

·         Prostate Cancer

·         Kidney Cancer

·         Bone & Bone Marrow Cancer

·         Other Cancers

·         Wound Applications

·         Other Applications

By Procedure

·         Image-guided Procedures

·         Ultrasound-guided Procedures

·         Stereotactic Procedures

·         CT-guided Procedures

·         MRI-guided Procedures

·         Other Image-guided Procedures

·         Nonimage-guided Procedures

By End User

·         Hospitals & surgical centers

·         Diagnostic Clinics & pathology laboratories

·         Ambulatory care centers

·         Research & Academic Institutes

Regional Outlook

·         Asia Pacific

·         North America

·         Latin America

·         Middle East and Africa

·         Europe

Aspiration Needle and Biopsy Needle Market by Product Type Segmentation

On the basis of the product type, the Aspiration Needle and Biopsy Needle Market is segmented into biopsy needles and aspiration needles. Biopsy needles represent the leading segment by product type, due to their widespread adoption in healthcare facilities and increasing preference for minimally invasive procedures.


Rising prevalence of cancer and increasing demand for minimally invasive procedures are driving growth in the market. Aspiration needles are primarily used for obtaining fluid or tissue samples from the body through a minimally invasive procedure called fine needle aspiration. Aspiration needles are used in cytology and diagnostic sampling, in which diagnostic conditions like infections, inflammatory diseases, or cancers exist. High public awareness about the cancer and other chronic diseases promote early diagnosis, increasing the demand for aspiration, and biopsy needles. Regular screening programs and campaign led by government and private organizations are driving growth in the market.

Regional Outlook

On the basis of the regions, the Aspiration Needle and Biopsy Needle Market is segmented into Asia Pacific, North America, Latin America, the Middle East and Africa, and Europe. Asia Pacific is the leading segment due to increasing population growth and rising awareness among people about early diagnosis and treatment of chronic diseases. Rising healthcare expenditure in countries like India, China, and Japan is witnessing significant growth in the market. Rising research activities are driving growth significantly in the market.

The Asia-Pacific biopsy devices and needles market is poised for substantial growth in the coming years, driven by increasing healthcare needs, technological advancements, and a focus on early disease detection. Rising healthcare expenditure in the region is driving growth in the market significantly. The growing prevalence of age-related and lifestyle-related cancers fuels the trend. Rapid improvement in healthcare infrastructure, particularly in emerging economies, has enhanced access to advanced diagnostic procedures.

This has led to increased adoption in biopsy and needle-based techniques. North America is one of the leading segments in aspiration needles and biopsy needles and is expected to dominate the market during the forecast period. High prevalence of chronic diseases, such as liver diseases, cancer, and kidney diseases, are the key factors behind the significant growth. Region is equipped with advanced healthcare facilities and cutting-edge diagnostic technologies, making it a global leader in medical procedures requiring aspiration and biopsy needles.

Companies in North America invest heavily in research and development to introduce advanced needle designs, such as those with better accuracy and patient safety. With an aging population more prone to chronic diseases, the demand for diagnostic procedures requiring biopsy and aspiration needles continues to rise. The presence of key players in the United States and Canada is the key reason behind the significant growth in the market.

Insurance companies and government programs in North America offer favorable reimbursement policies for biopsy procedures, reducing financial barriers and encouraging more patients to undergo these diagnostic tests. High public awareness regarding cancer and other chronic diseases promotes early diagnosis, increasing the demand for biopsy and aspiration needles. The U.S. and Canada are popular destinations for medical tourism due to their advanced diagnostic capabilities and high success rates, driving the market for aspiration and biopsy needles.


Key Players

·         CONMED Corporation

·         Medtronic Plc (Ireland)

·         Olympus Corporation

·         Becton Dickinson and Company

·         Boston Scientific Corporation

·         Cook Group Incorporated

·         Argon Medical Devices, Inc

·         INRAD Inc.

·         Somatex Medical Technologies

·         Stryker Corporation 

·         Cardinal Health

·         Remington Medical

·         Ranfac Corporation

·         HAKKO CO., LTD

·         Merit Medical Systems

·         Other Players

Buy Report